{"preqs":"PHA3011 and one of PHA3021, BMS3021 or BMS3031","creditPoints":6,"rules":[{"startDate":"1/01/2013","status":"ACTIVE","ruleSummary":"TRANS","ruleString":"Unit was previously coded {PHA3032%}","endDate":""},{"startDate":"1/01/2013","status":"ACTIVE","ruleSummary":"PREREQ-IW","ruleString":"(Must have passed an (I/W) unit in {PHA3011} and  Must have passed an (I/W) unit in {BMS3021, BMS3031, PHA3021})","endDate":""}],"locationAndTime":[{"location":"Clayton","time":["Second semester 2017 (Day)"]}],"enjoyScore":4.733333333,"learnScore":4.673992674,"learnResponse":22,"proh":"","scaBand":2,"unitName":"Neuro and endocrine pharmacology","description":"This unit provides an integrated understanding of how drugs affect neuronal and endocrine function. Four major areas are covered: major neurotransmitters within the brain, reproductive endocrinology, metabolism and disorders of pancreatic and thyroid function, mood and pain, and, neurodegenerative disorders. The focus is on mechanisms of action, use and side effects of drugs affecting a range of neuronal and endocrine functions and includes topics such as drugs used in anaesthesia and sedation, anxiety, depression, epilepsy, schizophrenia and psychoses, Parkinson\u0027s and Alzheimer\u0027s disease, reproduction and contraception, diabetes, thyroid function and metabolism and calcium homeostasis.","enjoyResponse":46,"faculty":"Faculty of Science","unitCode":"PHA3032","eftsl":0.125}